In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion

Hepatology

Volumn 30, Issue 4, 1999, Pages 914-919

  Ozaki, Satoru ^a,b   Harada, Kenichi ^a   Sanzen, Takahiro ^a   Watanabe, Kishichiro ^b   Tsui, Wilson ^c   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c Caritas Medical Centre Hong Kong   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TELOMERASE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; CARCINOGENESIS; CELL IMMORTALIZATION; CONTROLLED STUDY; DYSPLASIA; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NUCLEIC ACID ANALYSIS; PRECANCER; PRIORITY JOURNAL; TUMOR GROWTH;

AGED; BILIARY TRACT DISEASES; CARRIER PROTEINS; CHOLANGIOCARCINOMA; COLON; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INTESTINAL MUCOSA; LITHIASIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; REFERENCE VALUES; RNA, MESSENGER; TELOMERASE;

EID: 0032836603     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300419     Document Type: Article

References (26)

1. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995:87:884-894.
2. Greider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987;51:887-898.
3. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59:521-529.
4. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-282.
5. Greider CW. Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Dev 1994;4:203-211.
6. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, lineality and sensitivity. Nucleic Acids Res 1995:23:3794-3795.
7. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, et al. The RNA component of human telomerase. Science 1995;269:1236-1241.
8. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO. A mammalian telomerase-associated protein. Science 1997;275:973-977.
9. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995;269:1267-1270.
10. Nakanuma Y, Hoso M, Terada T. Clinical and pathologic features of cholangiocarcinoma. In: Okuda K, Tabor E, eds. Liver Cancer. New York: Churchill Livingstone, pp 279-290,1997.
11. Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microscopy Res Tech 1997:38:552-570.
12. Nakanuma Y, Terada T, Tanaka Y, Ohta G. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch A Pathol Anat Histopathol 1985;406:45-58.
13. Terada T, Nakanuma Y, Ohta T, Nagakawa T. Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis. Histopathology 1992;21:233-240.
14. Sasaki M, Nakanuma Y, Kim YS. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. HEPATOLOGY 1996:24:1074-1078.
15. Miyazaki I, Inoue TO, Uchino J, Ozawa K, Orita K, Kakita A, Kurota S, et al. General Rules for Cancer of the Biliary Tract. Tokyo: Kanehara Pub., 1993.
16. Hiyama E, Hiyama K, Tatsumoto N, et al. Telomerase activity in human intestine. Int J Oncol 1996:9:453-458.
17. Chomezyneski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
18. Counter CM, Avilion AA, FeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992:11:1921-1929.
19. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-2736.
20. Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 1997;74:141-147.
21. Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997;112:493-500.
22. Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H, Kononen J. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 1997:150:1159-1164.
23. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;14:4240-4248.
24. Langford LA, Piatyszek MA, Schold SC Jr, Shay JW. Telomerase activity in human brain tumors. Lancet 1995;346:1267-1268.
25. Bergquist A, Galumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. HEPATOLOGY 1998:27:311-316.
26. Morales CP, Burdick JS, Saboorian MH, Wright WE, Shay JW. In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. Gastrointest Endosc 1998; 48:402-405.